Resources Repository
-
Resource PortalWeb Portal, Teaching Resource 2024Guide to Health Economic Analysis & Research
The Guide to Health Economic Analysis & Research (GEAR) is a resource platform which aims …
The Guide to Health Economic Analysis & Research (GEAR) is a resource platform which aims to equip researchers and policy makers in low- and middle-income countries (LMICs) with the skills to conduct health economics research. While health economics research is well established in high-income countries, it is less prevalent in LMICs. The portal contains information about methodological difficulties in LMICs and allows users to compare recommendations from selected national guidelines in high- and middle-income countries.…
Technology Assessment | Health/Medicine | Costing Methods | Cost-Effectiveness Analysis | Global | Graduate | Doctoral | Professional | Policy Translation -
OrganizationWeb Portal 2024MCDM
Founded in 1998 out of a special interest group on multi-criteria decision making, The International Society …
Founded in 1998 out of a special interest group on multi-criteria decision making, The International Society for Multi-Criteria Decision Making (MCDM) develops, tests, evaluates and applies methodologies for solving multiple criteria decision making problems. They foster interaction and research in the scientific field of multiple criteria decision making, and work with other organizations in the study of management from a quantitative perspective. Resources available from MCDM include conferences, lists of software used for multi-criteria decision making…
Technology Assessment | Health/Medicine | Priority Setting/Ethics | Decision Analysis | Cost-Effectiveness Analysis | Health Systems | Policy/Regulation | Business/Industry | Economics/Finance | Government/Law | Global -
OrganizationWeb Portal 2024ISPOR
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics …
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) exists to advance the policy, science, and practice of pharmacoeconomics (health economics) and health outcomes research. ISPOR publishes Value in Health, which contains original research articles in the areas of economic evaluation, outcomes research, and conceptual, methodological, and health policy articles. Beyond health economics and outcomes research resources, tools of ISPOR include strategic initiatives, publications, and member…
Technology Assessment | Health/Medicine | Preferences/Values | Priority Setting/Ethics | Costing Methods | Health Outcomes | Value of Information | Mathematical Models | Cost-Effectiveness Analysis | Operations Research | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Chronic Disease/Risk | Health Systems | Policy/Regulation | Business/Industry | Economics/Finance | Science/Technology | Global -
OrganizationWeb Portal 2024Results for Development
Results for Development (R4D) was founded in 2008, with a mission to create self-sustaining systems …
Results for Development (R4D) was founded in 2008, with a mission to create self-sustaining systems that support health, educated people, while ensuring that local change agents are in the driver’s seat, and that knowledge is transformed into action. Their work supports sustainable progress in health, education and nutrition, and puts data users at the center of all efforts. They develop tools - including dashboards, scorecards and performance metrics - in a way that is designed to solve practical…
Technology Assessment | Health/Medicine | Priority Setting/Ethics | Costing Methods | Evidence Synthesis | Infectious Diseases | Child/Nutrition | Health Systems | Climate/Environment | Education/Labor | Global -
Resource PortalWeb Portal, Teaching Resource 2024MIDAS
MIDAS is a collaborative network of research scientists who use computational, statistical and mathematical models …
MIDAS is a collaborative network of research scientists who use computational, statistical and mathematical models to understand infectious disease dynamics and thereby assist the nation to prepare for, detect and respond to infectious disease threats. Midas focuses on research topics such as: Dynamics of emergence and spread of pathogens; Identification and surveillance of infectious diseases; Effectiveness and consequences of intervention strategies; Host/pathogen interactions; Ecological, climatic, economic and evolutionary dimensions of infectious diseases; The roles of behavior and behavioral adaptation in…
Technology Assessment | Health/Medicine | Mathematical Models | Dynamic Transmission | Calibration/Validation | Dynamic Simulation | Risk Analysis | Cost-Effectiveness Analysis | Infectious Diseases | Health Systems | Policy/Regulation | Climate/Environment | Science/Technology | Global | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Conceptual Mapping | Quantitative Literacy -
Tutorial/PrimerInteractive, Teaching Resource 2017Health Technology Assessment (HTA) Glossary
The purpose of the HTA Glossary is to give the Health Technology Assessment (HTA) community …
The purpose of the HTA Glossary is to give the Health Technology Assessment (HTA) community – both producers and users of health technology assessment information – a common vocabulary. The HTA glossary is an official collaboration between International Network of Agencies for Health Technology Assessment (INAHTA), Health Technology Assessment international (HTAi) and other partner organizations. The English version of the HTA Glossary is coordinated by Adelaide Health Technology Assessment (AHTA), the French version by l'Institut…
Technology Assessment | Health/Medicine | High School | College | Graduate | Doctoral | Professional | Policy Translation -
ArticlePublication 2016Cost-Effectiveness of Hypertension Treatment According to 2014 Guidelines
This article compared the cost-effectiveness of hypertension treatment in non-Hispanic blacks and non-Hispanic whites according …
This article compared the cost-effectiveness of hypertension treatment in non-Hispanic blacks and non-Hispanic whites according to 2014 US hypertension treatment guidelines. The cardiovascular disease (CVD) policy model was used to simulate CVD events, quality-adjusted life years (QALYs), and treatment costs in 35- to 74-year-old adults with untreated hypertension. CVD incidence, mortality, and risk factor levels were obtained from cohort studies, hospital registries, vital statistics, and national surveys. The authors assumed a willingness-to-pay for health of…
Microsimulation | Health/Medicine | Cost-Effectiveness Analysis | Chronic Disease/Risk | North America -
ArticlePublication 2016Cost-Effectiveness of Blood Pressure Treatment Guidelines in Adults 35-74
In this article the authors used the CVD Policy Model to compare the cost-effectiveness of …
In this article the authors used the CVD Policy Model to compare the cost-effectiveness of conservative versus intensive blood pressure treatment guidelines in adult hypertensive patients aged 35 to 74 years. Outcomes included in the study were CVD events, treatment costs, quality-adjusted life years, and drug and monitoring costs projected over the years 2016 to 2026. The effectiveness and costs of hypertension were calculated for treatment according to the 2003 Joint National Committee (JNC)-7 or…
Microsimulation | Health/Medicine | Cost-Effectiveness Analysis | Chronic Disease/Risk | Clinical Care | North America -
BookPublication 2016Cost-Effectiveness in Health and Medicine, 2nd Edition
This is a revised and expanded edition of the original text on Cost-Effectiveness in Health and Medicine. The …
This is a revised and expanded edition of the original text on Cost-Effectiveness in Health and Medicine. The Second Panel on Cost-Effectiveness in Health and Medicine included experts drawn from academia, healthcare administration, and government. The book offers advice for conducting analyses to improve the allocation of health resources, and is intended for economists, policy analysts, hospital executives, and students across health, business, and humanities disciplines. New components of this edition, include an in-depth review of the past 20…
Technology Assessment | Health/Medicine | Preferences/Values | Priority Setting/Ethics | Costing Methods | Health Outcomes | Mathematical Models | Cost-Effectiveness Analysis | Health Systems | Policy/Regulation | Economics/Finance | Global | North America | Europe